Sterling Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$107K Sell
7,888
-50,639
-87% -$606K ﹤0.01% 1383
2026
Q1
$351K Buy
58,527
+13,071
+29% +$98.4K 0.01% 926
2025
Q4
$326K Sell
45,456
-705
-2% -$5.57K 0.01% 1155
2025
Q3
$493K Buy
46,161
+13,675
+42% +$134K 0.01% 940
2025
Q2
$314K Buy
32,486
+3,035
+10% +$31.3K ﹤0.01% 1144
2025
Q1
$439K Sell
29,451
-1,035
-3% -$15.9K 0.01% 900
2024
Q4
$455K Sell
30,486
-44,716
-59% -$729K 0.01% 959
2024
Q3
$1.44M Buy
+75,202
New +$1.56M 0.02% 473

Other funds holding OGN

Sterling Capital Management's OGN Position: Q2 2026 in Review

Sterling Capital Management reduced its Organon & Co (OGN) stake by 87% in Q2 2026, selling an estimated $606K and leaving 7,888 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #1383.

Sterling Capital Management first reported a position in OGN in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.44M in Q3 2024. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Sterling Capital Management held 7,888 shares of Organon & Co worth $107K as of Q2 2026.
  • Sterling Capital Management sold 50,639 Organon & Co shares in Q2 2026, an estimated $606K.
  • Organon & Co made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1383 holding.
  • Sterling Capital Management first reported a position in Organon & Co in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Organon & Co position peaked at $1.44M in Q3 2024.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.